USP Celebrates its 200th Anniversary

Published on: 

The company has various projects and launches scheduled for 2020 as part of its anniversary celebration.

The United States Pharmacopeia (USP), a nonprofit organization that builds trust in medicines, supplements, and foods through public quality standards that help assure quality and safety, announced that January 2020 marks its 200th anniversary.

According to a Jan. 6, 2020 company press release, USP has various projects and launches scheduled for 2020 as part of its anniversary celebration. The events include:

  • The launch of Trust TV on USP’s 200th anniversary hub. Physician, researcher, and author Dhruv Khullar will host the program, which will tackle challenges of misinformation in healthcare, along with Adam Berinsky, director of the Massachusetts Institute of Technology (MIT) Political Experiments Research Lab.

  • The 2020 Meeting of the USP Convention from May 3–6, 2020 in Washington DC. Over 460 members of the healthcare continuum will meet to advance access to quality medicines, elect USP's board of trustees and council of experts, and adopt high-level guiding resolutions and amend the USP bylaws.

  • A partnership with MIT’s Center for Collective Intelligence to develop scenarios on how trust in medicine and healthcare will evolve through MIT’s online platform, the Trust CoLab.

  • The launch of Trust eXperience at TEDMED 2020. The new project gives users the opportunity to discover how quality medicines help people live longer and healthier lives through a digital visualization experience that explores USP public quality standards and the medicines used to treat humanity's deadliest diseases.

  • The reopening of the USP Museum in USP's Rockville, Maryland, headquarters in fall 2020.

"Billions of people live longer and healthier lives thanks to medicines they can trust," said Ronald T. Piervincenzi, PhD, CEO, USP, in the press release. "Our public quality standards build patient, practitioner, and industry confidence by setting clear quality expectations and increasing patient access to vital therapies. Governments in the US and around the world rely on the thousands of USP standards to make sure quality medicines are available to their populations, and that poor-quality and counterfeit drugs do not enter the market."

"We're working to help ensure that today's remarkable innovations can be tomorrow's trusted therapies, just as we have done for 200 years," Piervincenzi added.

Source: USP